FDA intends to further enhance its risk-based inspection model to prioritize inspections of compounding pharmacies that operate on larger scales and ship compounded drugs across multiple state lines. The agency released a guide for outsourcing facilities that provides clear instructions on issues such as how to submit product reports, how to register with FDA, and how to pay fees. FDA also began publishing outsourcing facility product reports.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
